The authors report that over-expressed POU4F1 contributed to the acquired resistance of melanoma cells to Vemurafenib. POU4F1 also promoted the activation of ERK signaling pathway via transcriptional regulation on MEK expression.
[Cell Death & Disease]
Liu, L., Yue, Q., Ma, J., Liu, Y., Zhao, T., Guo, W., Zhu, G., Guo, S., Wang, S., Gao, T., Li, C., & Shi, Q. (2020). POU4F1 promotes the resistance of melanoma to BRAF inhibitors through MEK/ERK pathway activation and MITF up-regulation. Cell Death & Disease, 11(6), 1–11. https://doi.org/10.1038/s41419-020-2662-2 Cite
0